View in EDS PDF Full Text

Psychotropic Medication and Psychosocial Service Use among Transition Age Youth with Autism Spectrum Disorder

Saved in:
Bibliographic Details
Title: Psychotropic Medication and Psychosocial Service Use among Transition Age Youth with Autism Spectrum Disorder
Language: English
Authors: Emma R. Plourde, Mir M. Ali, Kristina D. West
Source: American Journal on Intellectual and Developmental Disabilities. 2024 129(1):1-9.
Availability: American Association on Intellectual and Developmental Disabilities. P.O. Box 1897, Lawrence, KS 66044-1897. Tel: 785-843-1235; Fax: 785-843-1274; e-mail: AJMR@allenpress.com; Web site: https://meridian.allenpress.com/aaidd
Peer Reviewed: Y
Page Count: 9
Publication Date: 2024
Document Type: Journal Articles
Reports - Research
Descriptors: Autism Spectrum Disorders, Mental Health, Youth, Adolescents, Young Adults, Psychological Needs, Individual Development, Mental Health Programs, Drug Therapy, Transitional Programs
DOI: 10.1352/1944-7558-129.1.1
ISSN: 1944-7515
1944-7558
Abstract: People with autism spectrum disorder (ASD) experience high rates of psychotropic medication utilization and barriers to psychosocial services, yet limited literature explores use of these services and the association between a mental health condition (MH) and use. Using national multipayer claims data, this study estimates a multinomial logistic regression model to discern psychotropic medication and psychosocial service use among transition age youth (TAY) with ASD (12-26 years; N = 52,083) compared to a matched cohort of those without ASD (12-26 years; N = 52,083). Approximately one-third of TAY with ASD and no MH condition receive only psychotropic medication and the likelihood of using both psychosocial services and medication is higher only when TAY with ASD have a co-occurring MH condition.
Abstractor: As Provided
Entry Date: 2024
Accession Number: EJ1412479
Database: ERIC
FullText Links:
  – Type: pdflink
    Url: https://content.ebscohost.com/cds/retrieve?content=AQICAHj0k_4E0hTGH8RJwT4gCJyBsGNe_WN95AvKlDbXJGqwxwEKOjqJrRoVh02eClzxp6dmAAAA4jCB3wYJKoZIhvcNAQcGoIHRMIHOAgEAMIHIBgkqhkiG9w0BBwEwHgYJYIZIAWUDBAEuMBEEDI7LhPuAQPf3yws68gIBEICBmjlJVV8YiptR6EXWlbiNMlEKyKK3QpH_cBPXU0SeCg-z248P5xxSw56XrJH1Q3QvCdwrmarOs4IbXt5MrBtTJPVTcPIi3Sp8A0uGAvwaSj4NM63FfKg0Ge0xfKO_L6sWCoR2TI3O1MLfXODzDKzD7nOwIlRn9HOEos9sPbG-ncUVH1__zuSkyKsB5nNTz5YyPAJux03QdfVxsWk=
Text:
  Availability: 0
Header DbId: eric
DbLabel: ERIC
An: EJ1412479
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Psychotropic Medication and Psychosocial Service Use among Transition Age Youth with Autism Spectrum Disorder
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Emma+R%2E+Plourde%22">Emma R. Plourde</searchLink><br /><searchLink fieldCode="AR" term="%22Mir+M%2E+Ali%22">Mir M. Ali</searchLink><br /><searchLink fieldCode="AR" term="%22Kristina+D%2E+West%22">Kristina D. West</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="SO" term="%22American+Journal+on+Intellectual+and+Developmental+Disabilities%22"><i>American Journal on Intellectual and Developmental Disabilities</i></searchLink>. 2024 129(1):1-9.
– Name: Avail
  Label: Availability
  Group: Avail
  Data: American Association on Intellectual and Developmental Disabilities. P.O. Box 1897, Lawrence, KS 66044-1897. Tel: 785-843-1235; Fax: 785-843-1274; e-mail: AJMR@allenpress.com; Web site: https://meridian.allenpress.com/aaidd
– Name: PeerReviewed
  Label: Peer Reviewed
  Group: SrcInfo
  Data: Y
– Name: Pages
  Label: Page Count
  Group: Src
  Data: 9
– Name: DatePubCY
  Label: Publication Date
  Group: Date
  Data: 2024
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: Journal Articles<br />Reports - Research
– Name: Subject
  Label: Descriptors
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Autism+Spectrum+Disorders%22">Autism Spectrum Disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+Health%22">Mental Health</searchLink><br /><searchLink fieldCode="DE" term="%22Youth%22">Youth</searchLink><br /><searchLink fieldCode="DE" term="%22Adolescents%22">Adolescents</searchLink><br /><searchLink fieldCode="DE" term="%22Young+Adults%22">Young Adults</searchLink><br /><searchLink fieldCode="DE" term="%22Psychological+Needs%22">Psychological Needs</searchLink><br /><searchLink fieldCode="DE" term="%22Individual+Development%22">Individual Development</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+Health+Programs%22">Mental Health Programs</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+Therapy%22">Drug Therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Transitional+Programs%22">Transitional Programs</searchLink>
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1352/1944-7558-129.1.1
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1944-7515<br />1944-7558
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: People with autism spectrum disorder (ASD) experience high rates of psychotropic medication utilization and barriers to psychosocial services, yet limited literature explores use of these services and the association between a mental health condition (MH) and use. Using national multipayer claims data, this study estimates a multinomial logistic regression model to discern psychotropic medication and psychosocial service use among transition age youth (TAY) with ASD (12-26 years; N = 52,083) compared to a matched cohort of those without ASD (12-26 years; N = 52,083). Approximately one-third of TAY with ASD and no MH condition receive only psychotropic medication and the likelihood of using both psychosocial services and medication is higher only when TAY with ASD have a co-occurring MH condition.
– Name: AbstractInfo
  Label: Abstractor
  Group: Ab
  Data: As Provided
– Name: DateEntry
  Label: Entry Date
  Group: Date
  Data: 2024
– Name: AN
  Label: Accession Number
  Group: ID
  Data: EJ1412479
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=eric&AN=EJ1412479
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1352/1944-7558-129.1.1
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 1
    Subjects:
      – SubjectFull: Autism Spectrum Disorders
        Type: general
      – SubjectFull: Mental Health
        Type: general
      – SubjectFull: Youth
        Type: general
      – SubjectFull: Adolescents
        Type: general
      – SubjectFull: Young Adults
        Type: general
      – SubjectFull: Psychological Needs
        Type: general
      – SubjectFull: Individual Development
        Type: general
      – SubjectFull: Mental Health Programs
        Type: general
      – SubjectFull: Drug Therapy
        Type: general
      – SubjectFull: Transitional Programs
        Type: general
    Titles:
      – TitleFull: Psychotropic Medication and Psychosocial Service Use among Transition Age Youth with Autism Spectrum Disorder
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Emma R. Plourde
      – PersonEntity:
          Name:
            NameFull: Mir M. Ali
      – PersonEntity:
          Name:
            NameFull: Kristina D. West
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1944-7515
            – Type: issn-electronic
              Value: 1944-7558
          Numbering:
            – Type: volume
              Value: 129
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: American Journal on Intellectual and Developmental Disabilities
              Type: main
ResultId 1